Literature DB >> 17150545

Designing and analysis of a potent bi-functional aptamers that inhibit protease and helicase activities of HCV NS3.

Takuya Umehara1, Kotaro Fukuda, Fumiko Nishikawa, Satoru Sekiya, Michinori Kohara, Tsunemi Hasegawa, Satoshi Nishikawa.   

Abstract

Nonstructural protein 3 (NS3) of hepatitis C virus (HCV) is a multi-functional enzyme having protease and helicase activities. NS3 is essential for HCV replication and proliferation. Previously, we obtained RNA aptamers against NS3 protease domain (Protease aptamer; deltaNEO-III and G9-II) and helicase domain (helicase aptamer; #5), and they inhibited the enzyme activities, respectively. We designed and constructed new bi-functional aptamers NEO-35-sX and G925-sX (X: 5-51 nts) by conjugating protease and helicase aptamers via oligo U spacer. Some of them showed 10-fold higher helicase inhibition than helicase aptamer #5 alone.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 17150545     DOI: 10.1093/nass/48.1.195

Source DB:  PubMed          Journal:  Nucleic Acids Symp Ser (Oxf)        ISSN: 0261-3166


  10 in total

1.  The interdomain interface in bifunctional enzyme protein 3/4A (NS3/4A) regulates protease and helicase activities.

Authors:  Cihan Aydin; Sourav Mukherjee; Alicia M Hanson; David N Frick; Celia A Schiffer
Journal:  Protein Sci       Date:  2013-10-19       Impact factor: 6.725

2.  Robust suppression of HIV replication by intracellularly expressed reverse transcriptase aptamers is independent of ribozyme processing.

Authors:  Margaret J Lange; Tarun K Sharma; Angela S Whatley; Linda A Landon; Michael A Tempesta; Marc C Johnson; Donald H Burke
Journal:  Mol Ther       Date:  2012-09-04       Impact factor: 11.454

Review 3.  Prospects for nucleic acid-based therapeutics against hepatitis C virus.

Authors:  Chang Ho Lee; Ji Hyun Kim; Seong-Wook Lee
Journal:  World J Gastroenterol       Date:  2013-12-21       Impact factor: 5.742

Review 4.  Unzippers, resolvers and sensors: a structural and functional biochemistry tale of RNA helicases.

Authors:  Ana Lúcia Leitão; Marina C Costa; Francisco J Enguita
Journal:  Int J Mol Sci       Date:  2015-01-22       Impact factor: 5.923

Review 5.  Aptamers in diagnostics and treatment of viral infections.

Authors:  Tomasz Wandtke; Joanna Woźniak; Piotr Kopiński
Journal:  Viruses       Date:  2015-02-16       Impact factor: 5.048

Review 6.  Aptamers for Anti-Viral Therapeutics and Diagnostics.

Authors:  Tae-Hyeong Kim; Seong-Wook Lee
Journal:  Int J Mol Sci       Date:  2021-04-17       Impact factor: 5.923

7.  Nucleic acid aptamers for targeting of shRNA-based cancer therapeutics.

Authors:  John S Vorhies; John J Nemunaitis
Journal:  Biologics       Date:  2007-12

Review 8.  Aptamers against pathogenic microorganisms.

Authors:  Anna Davydova; Maria Vorobjeva; Dmitrii Pyshnyi; Sidney Altman; Valentin Vlassov; Alya Venyaminova
Journal:  Crit Rev Microbiol       Date:  2015-08-10       Impact factor: 7.624

Review 9.  Oligonucleotide aptamers: potential novel molecules against viral hepatitis.

Authors:  Mina Mirian; Hossein Khanahmad; Leila Darzi; Mansour Salehi; Hojjat Sadeghi-Aliabadi
Journal:  Res Pharm Sci       Date:  2017-04

10.  Pharmacokinetics of a Cholesterol-conjugated Aptamer Against the Hepatitis C Virus (HCV) NS5B Protein.

Authors:  Chang Ho Lee; Soo-Han Lee; Ji Hyun Kim; Yook-Hwan Noh; Gyu-Jeong Noh; Seong-Wook Lee
Journal:  Mol Ther Nucleic Acids       Date:  2015-10-06       Impact factor: 10.183

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.